Home
Conditions
SARS CoV 2 Infection

Clinical trial condition

SARS CoV 2 Infection

Explore clinical trials studying SARS CoV 2 Infection. Study availability and eligibility vary by location and protocol.

59 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

SARS CoV 2 Infection trial results

Active, not recruiting

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

NCT05421208

Conditions: Autonomic Nervous System Diseases, COVID-19, Chronic Disease, +23 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Active, not recruiting

CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2

NCT05467930

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Active, not recruiting

NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19

NCT05292274

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: NYU Langone Health New York, United States

View Trial Details

Active, not recruiting

Transplacental Transmission of RSV (TTRSV)

NCT05443607

Conditions: Asthma, Bronchial Diseases, Bronchiolitis, +20 more
Locations: Tulane University Lakeside Hospital Metairie, Louisiana, United States

Ochsner Baptist Hospital New Orleans, Louisiana, United States

View Trial Details

Active, not recruiting

CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools

NCT06640387

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +25 more
Locations: The Hospital for Sick Children (SickKids) Toronto, Ontario, Canada

View Trial Details

Active, not recruiting

Pancoronavirus Vaccine Study in Healthy Adults

NCT06950177

Conditions: COVID-19, COVID-19 Respiratory Infection, COVID-19 Vaccine, +12 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Active, not recruiting

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations

NCT05667597

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Sciensano Brussels, Belgium

View Trial Details

Completed

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

NCT05148845

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Nelson Mandela Academic Clinical Research Unit (NeMACRU) Mthatha, Eastern Cape, South Africa

PHOENIX Pharma Pty Ltd Port Elizabeth, Eastern Cape, South Africa

Josha Research Bloemfontein, Free State, South Africa

Perinatal HIV Research Unit (PHRU), SOWETO Johannesburg, Gauteng, South Africa

View all 31 locations

View Trial Details

Completed

Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States

NCT06633835

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: University of Utah School of Medicine Salt Lake City, Utah, United States

View Trial Details

Completed

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

NCT06234956

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Hospital Vall Hebron Barcelona, Spain

CAP Centelles Centelles, Barcelona, Spain

Hospital Josep Trueta Girona, Spain

CAP Peralada Peralada, Girona, Spain

View Trial Details

SARS CoV 2 Infection

SARS CoV 2 Infection trial results

Related conditions